Inspire Medical Systems Inc INSP

NYS: INSP | ISIN: US4577301090   3/05/2024
249,72 USD (-0,59%)
(-0,59%)   3/05/2024
Grafiek Inspire Medical Systems Inc Grafiek Inspire Medical Systems Inc
dinsdag 7 mei 2024, 22:00
Kwartaalcijfers (1ste kwartaal)

Inspire Medical Systems Inc in het nieuws

16 februari 2024 · INSPIRE MEDICAL SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options · Persbericht

15 februari 2024 · INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit · Persbericht

13 februari 2024 · Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before February 20, 2024 to Discuss Your Rights - INSP · Persbericht

9 februari 2024 · INSPIRE MEDICAL SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options · Persbericht

3 februari 2024 · INSPIRE MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inspire Medical Systems, Inc. - INSP · Persbericht

2 februari 2024 · INSPIRE MEDICAL SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options · Persbericht

1 februari 2024 · INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit · Persbericht

25 januari 2024 · INSPIRE MEDICAL INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options · Persbericht

20 januari 2024 · INSPIRE MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inspire Medical Systems, Inc. - INSP · Persbericht

18 januari 2024 · INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit · Persbericht

Profiel Inspire Medical Systems Inc

Inspire is een medisch technologiebedrijf dat zich richt op de ontwikkeling en commercialisering van innovatieve en minimaal invasieve oplossingen voor patiënten met obstructieve slaapapneu. Inspire's eigen Inspire therapie is de eerste en enige door de FDA goedgekeurde neurostimulatie technologie die een veilige en effectieve behandeling biedt voor matige tot ernstige obstructieve slaapapneu.

Gezondheidstechnologie
Medische Specialiteiten

Website: www.inspiremedicalsystems.com

Hoofdzetel: Golden Valley, Minnesota vlag Verenigde Staten

CEO: Timothy Herbert

Werknemers: 755

Aandelen Inspire Medical Systems Inc

Beurswaarde: 7,61 miljard USD

Effecten: 30,30 miljoen

Winst per aandeel (12 maand):  PLUS

Beta: 1,64

Mijn selecties